The same question was asked almost exactly two years ago. Repeating the same reply with minor edits:
This has been a topic of a debate among syphilis experts for decades. There are no data at all on whether there is benefit (e.g. in preventing later relapse) in adding low-dose but long-acting penic...
Comments
at Stanford Health Care I may have weighed in on this previously as well. ...
at Cooperman Barnabas Medical Center Dear Dr. @Handsfield,
If memory serves, early lat...
at University of Washington Center for AIDS and STD If I correctly recall, somewhere in the mists of s...
at Cooperman Barnabas Medical Center Thank you, Dr. Handsfield.
And what? A syphilis t...
I agree with everything written here by Dr. @Handsfield. At the risk of biasing the discussion, I'd like to add that one potential, purely logistical, system-dependent benefit of providing a dose of BPG at the end of the IV penicillin course is to create a touchpoint between a patient and the health...
I may have weighed in on this previously as well. ...
Dear Dr. @Handsfield, If memory serves, early lat...
If I correctly recall, somewhere in the mists of s...
Thank you, Dr. Handsfield. And what? A syphilis t...